X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3256) 3256
Publication (319) 319
Book / eBook (58) 58
Book Review (44) 44
Book Chapter (19) 19
Newsletter (17) 17
Dissertation (7) 7
Newspaper Article (7) 7
Conference Proceeding (5) 5
Data Set (2) 2
Transcript (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2205) 2205
index medicus (1886) 1886
animals (1167) 1167
female (912) 912
male (896) 896
multidisciplinary sciences (762) 762
hematology (730) 730
medicine (689) 689
research article (671) 671
science (633) 633
proteins (582) 582
research (571) 571
risk factors (521) 521
mice (516) 516
anticoagulants (492) 492
middle aged (471) 471
immunology (456) 456
adult (433) 433
analysis (418) 418
thrombosis (394) 394
inflammation (366) 366
aged (359) 359
thrombin (358) 358
peripheral vascular disease (354) 354
coagulation (349) 349
gene expression (331) 331
health aspects (307) 307
tissue factor (305) 305
cell biology (301) 301
biochemistry (298) 298
activation (289) 289
biology (289) 289
physiological aspects (281) 281
cancer (271) 271
time factors (263) 263
signal transduction (261) 261
expression (259) 259
genetic aspects (246) 246
blood (244) 244
biology and life sciences (242) 242
studies (242) 242
care and treatment (239) 239
oncology (229) 229
biochemistry & molecular biology (228) 228
patients (226) 226
rodents (221) 221
blood coagulation (219) 219
anticoagulants - therapeutic use (216) 216
heparin (214) 214
medicine and health sciences (211) 211
thromboembolism (206) 206
cytokines (203) 203
factor xa (200) 200
molecular sequence data (198) 198
genes (188) 188
amino acid sequence (182) 182
article (181) 181
factor xa - metabolism (178) 178
laboratories (178) 178
medical research (178) 178
mortality (178) 178
protein binding (177) 177
rivaroxaban (174) 174
antibodies (172) 172
genetics (172) 172
apoptosis (171) 171
enzymes (170) 170
physiology (169) 169
venous thromboembolism (168) 168
cells, cultured (167) 167
treatment outcome (165) 165
blood coagulation - drug effects (164) 164
disease (163) 163
plasma (163) 163
rats (158) 158
cells (157) 157
kinases (157) 157
prevention (157) 157
binding (154) 154
adolescent (152) 152
thrombin - metabolism (151) 151
mutation (150) 150
thromboplastin - metabolism (150) 150
drug therapy (149) 149
factor xa inhibitors (143) 143
factor-xa (142) 142
binding sites (141) 141
disease models, animal (139) 139
endothelial-cells (139) 139
usage (139) 139
pharmacology (137) 137
warfarin (137) 137
aged, 80 and over (135) 135
risk (135) 135
mice, inbred c57bl (134) 134
anticoagulants - adverse effects (133) 133
pharmacology & pharmacy (132) 132
infections (131) 131
blood-coagulation (128) 128
in-vitro (128) 128
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
UTL at Downsview - May be requested (4) 4
UofT at Mississauga - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Engineering & Comp. Sci. - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Providence Healthcare - Stacks (2) 2
UofT at Mississauga - Reference (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Online Resources - Online (1) 1
Robarts - Reference (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3334) 3334
Russian (6) 6
Spanish (6) 6
French (4) 4
German (2) 2
Japanese (2) 2
Chinese (1) 1
Italian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 05/2017, Volume 15, Issue 5, pp. 931 - 937
Background: FXa(I16L) (PF-05230907) is a zymogen-like variant of activated factor X (FXa). It shows enhanced resistance to inactivation by endogenous... 
clinical trial | hematologic agents | hemorrhagic disorders | blood coagulation factor | 05230907 | activated partial thromboplastin time | PF-05230907 | HUMAN-PLASMA | ACTIVATION | PROTEIN | BYPASS | FACTOR-VIII | SPONTANEOUS INTRACEREBRAL HEMORRHAGE | THROMBIN GENERATION | INHIBITION | HEMOPHILIA-A | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Factor Xa - administration & dosage | Injections, Intravenous | Area Under Curve | Fibrin Fibrinogen Degradation Products - metabolism | Humans | Prothrombin Time | Half-Life | Male | Metabolic Clearance Rate | Recombinant Proteins | Healthy Volunteers | Young Adult | Peptide Hydrolases - blood | Antithrombin III | Coagulants - administration & dosage | Peptide Fragments - blood | Adult | Coagulants - pharmacokinetics | Factor Xa - adverse effects | Factor Xa - immunology | Double-Blind Method | Factor Xa - pharmacokinetics | Biomarkers - blood | Blood Coagulation - drug effects | Partial Thromboplastin Time | Adolescent | Prothrombin | Antibodies - blood | Coagulants - adverse effects | Coagulants - immunology | Coagulation factor X | Pharmacodynamics | Intravenous administration | Toxicity | Coagulation | Clinical trials | Thrombin | Antithrombin | Hemorrhage | Bleeding | Antibody response | Proenzymes | Thromboplastin | Coagulation factors | Immunogenicity | Plasma levels | Pharmacokinetics
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2013, Volume 288, Issue 30, pp. 21569 - 21580
Journal Article
American Journal of Hematology, ISSN 0361-8609, 02/2012, Volume 87, Issue 2, pp. 194 - 196
Journal Article
Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 24, pp. 5871 - 5878
Journal Article
Journal Article
Blood Coagulation & Fibrinolysis, ISSN 0957-5235, 06/2011, Volume 22, Issue 4, pp. 247 - 253
Journal Article
EBioMedicine, ISSN 2352-3964, 03/2016, Volume 5, Issue C, pp. 175 - 182
Journal Article